EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Tailoring CAR surface density and dynamics to improve CAR-T cell therapy

Ana Hinckley-Boned, Carmen Barbero-Jiménez, Maria Tristán-Manzano, Noelia Maldonado-Perez, Michael Hudecek, Pedro Justicia-Lirio, Francisco Martin

Journal for ImmunoTherapy of Cancer · 2025-04 · 13 (4) · e010702

DOI: 10.1136/jitc-2024-010702 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 29.04.2025. Verfasst von Ana Hinckley-Boned und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, Pfizer-University of Granada-Andalusian Regional Government Centre for Genomics and Oncological Research (GENYO), PTS…. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Receptors, Antigen, T-Cell, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Centro para el Desarrollo Tecnológico Industrial, Agencia Nacional de Promoción Científica y Tecnológica, Consejería de Salud y Familias, Junta de Andalucía.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR)-T cell therapy has revolutionized the treatment landscape for relapsed and/or refractory B-cell neoplasms, garnering Food and Drug Administration/European Medicines Agency approval for six commercial products. Despite this success, challenges persist, including a relapse rate of 30–50% in hematologic tumors, limited clinical efficacy in solid tumors, and severe side effects. This review addresses the critical need for therapeutic enhancement by focusing on the often-overlooked strategy of modulating CAR protein density on the cell membrane. We delve into the key factors influencing CAR surface expression, such as CAR downmodulation following antigen encounter and antigen-related factors. The dynamics of CAR downmodulation remain underexplored; however, recent data point to its modification as a useful tool for improving functionality. Notably, transcriptional control of CAR expression and the incorporation of specific elements into the CAR design have emerged as interesting strategies to tailor CAR expression profiles. Therefore, controlling CAR dynamic density may represent an attractive strategy for achieving optimal therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveReceptors, Chimeric AntigenReceptors, Antigen, T-CellNeoplasmsHumans

Stichwörter der Autor:innen

Antigen receptor designChimeric antigen receptor - CARImmunotherapySolid tumorT cell Receptor - TCR

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Genomic Medicine, Pfizer-University of Granada-Andalusian Regional Government Centre for Genomics and Oncological Research (GENYO), PTS, Granada, Spain.
  • LentiStem Biotech, Pfizer-University of Granada-Andalusian Regional Government Centre for Genomics and Oncological Research (GENYO), PTS, Granada, Andalusia, Spain.
  • Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.
  • Department of Biochemistry and Molecular Biology III and Immunology, Faculty of Medicine, University of Granada, Granada, Spain.
  • Biosanitary Research Institute of Granada (ibs.GRANADA), University of Granada, Granada, Spain.
  • Brain Tumor and Immune Cell Engineering Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Förderung

  • Centro para el Desarrollo Tecnológico Industrial
  • Agencia Nacional de Promoción Científica y Tecnológica
  • Consejería de Salud y Familias, Junta de Andalucía
  • Instituto de Salud Carlos III

Zitieren

APA

Hinckley-Boned, A., Barbero-Jiménez, C., Tristán-Manzano, M., Maldonado-Perez, N., Hudecek, M., Justicia-Lirio, P., & Martin, F. (2025). Tailoring CAR surface density and dynamics to improve CAR-T cell therapy. Journal for ImmunoTherapy of Cancer, 13(4), e010702. https://doi.org/10.1136/jitc-2024-010702

Vancouver

Hinckley-Boned A, Barbero-Jiménez C, Tristán-Manzano M, Maldonado-Perez N, Hudecek M, Justicia-Lirio P, et al. Tailoring CAR surface density and dynamics to improve CAR-T cell therapy. Journal for ImmunoTherapy of Cancer. 2025;13(4):e010702. doi:10.1136/jitc-2024-010702

BibTeX
@article{HinckleyBoned2025,
  author = {Hinckley-Boned, Ana and Barbero-Jiménez, Carmen and Tristán-Manzano, Maria and Maldonado-Perez, Noelia and Hudecek, Michael and Justicia-Lirio, Pedro and Martin, Francisco},
  title = {Tailoring CAR surface density and dynamics to improve CAR-T cell therapy},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  volume = {13},
  number = {4},
  pages = {e010702},
  doi = {10.1136/jitc-2024-010702}
}
Kostenlos starten →